MORGAN STANLEY - ALX ONCOLOGY HLDGS INC ownership

ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 58 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$1,600,718
-12.2%
333,483
+37.3%
0.00%
Q2 2023$1,823,774
+28.4%
242,846
-22.7%
0.00%
Q1 2023$1,420,123
-74.1%
314,186
-35.4%
0.00%
-100.0%
Q4 2022$5,480,803
+44.4%
486,318
+22.6%
0.00%0.0%
Q3 2022$3,796,000
+5.7%
396,637
-10.7%
0.00%
Q2 2022$3,592,000
-44.7%
443,935
+15.5%
0.00%
-100.0%
Q1 2022$6,497,000
+18.7%
384,518
+51.0%
0.00%0.0%
Q4 2021$5,473,000
-9.0%
254,700
+212.8%
0.00%0.0%
Q3 2021$6,014,000
+8.9%
81,420
-19.4%
0.00%0.0%
Q2 2021$5,523,000
+1543.8%
101,009
+2116.6%
0.00%
Q1 2021$336,000
-69.0%
4,557
-63.7%
0.00%
Q4 2020$1,083,000
+1404.2%
12,564
+561.6%
0.00%
Q3 2020$72,0001,8990.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q3 2020
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$163,929,00036.34%
Logos Global Management LP 3,011,352$50,892,0006.60%
Vivo Capital, LLC 4,220,048$71,319,0004.91%
Samsara BioCapital, LLC 262,786$4,441,0001.12%
Cormorant Asset Management, LP 712,079$12,034,0000.92%
Pier Capital, LLC 394,443$6,666,0000.85%
Redmile Group, LLC 772,397$13,054,0000.41%
Artal Group S.A. 500,000$8,450,0000.35%
Nan Fung Group Holdings Ltd 41,950$709,0000.34%
Orbimed Advisors 621,700$10,507,0000.17%
View complete list of ALX ONCOLOGY HLDGS INC shareholders